Natixis Advisors LLC Has $238,000 Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Natixis Advisors LLC cut its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 34.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,049 shares of the company’s stock after selling 7,008 shares during the period. Natixis Advisors LLC’s holdings in Privia Health Group were worth $238,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. KBC Group NV raised its holdings in Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after acquiring an additional 871 shares in the last quarter. MQS Management LLC acquired a new position in Privia Health Group in the 3rd quarter valued at $217,000. Victory Capital Management Inc. raised its holdings in Privia Health Group by 402.9% in the 3rd quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock valued at $3,260,000 after acquiring an additional 143,446 shares in the last quarter. GSA Capital Partners LLP raised its holdings in Privia Health Group by 228.1% in the 3rd quarter. GSA Capital Partners LLP now owns 50,975 shares of the company’s stock valued at $928,000 after acquiring an additional 35,439 shares in the last quarter. Finally, Olympiad Research LP acquired a new position in Privia Health Group in the 3rd quarter valued at $195,000. 94.48% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Privia Health Group

In other Privia Health Group news, CEO Parth Mehrotra sold 135,142 shares of the company’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the sale, the chief executive officer now owns 247,771 shares in the company, valued at approximately $4,583,763.50. The trade was a 35.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 14.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on PRVA shares. Truist Financial lifted their price target on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Barclays lifted their price target on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, November 8th. JPMorgan Chase & Co. lifted their price target on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday. Royal Bank of Canada reiterated an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a research note on Wednesday, August 14th. Finally, KeyCorp started coverage on Privia Health Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $23.00 price target on the stock. Two research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $24.93.

Privia Health Group Trading Down 0.8 %

NASDAQ PRVA opened at $21.48 on Friday. The business’s 50-day moving average price is $19.24 and its two-hundred day moving average price is $18.69. Privia Health Group, Inc. has a 12 month low of $15.92 and a 12 month high of $24.30. The firm has a market capitalization of $2.58 billion, a PE ratio of 214.82, a price-to-earnings-growth ratio of 5.45 and a beta of 0.76.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.